Item Type | Name |
Academic Article
|
Characterization of a murine p53ser246 mutant equivalent to the human p53ser249 associated with hepatocellular carcinoma and aflatoxin exposure.
|
Academic Article
|
Developmental control of transcription of the CAT reporter gene by a truncated mouse alphafetoprotein gene regulatory region in transgenic mice.
|
Academic Article
|
Mammary tumor modifiers in BALB/cJ mice heterozygous for p53.
|
Academic Article
|
A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.
|
Academic Article
|
Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor.
|
Academic Article
|
MDM2 as MYCN transcriptional target: implications for neuroblastoma pathogenesis.
|
Academic Article
|
Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma.
|
Academic Article
|
20 years studying p53 functions in genetically engineered mice.
|
Academic Article
|
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation.
|
Academic Article
|
Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models.
|
Academic Article
|
p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.
|
Academic Article
|
The cenpB gene is not essential in mice.
|
Academic Article
|
An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations.
|
Academic Article
|
Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity.
|
Concept
|
Mammary Tumor Virus, Mouse
|
Concept
|
Mice, Inbred MRL lpr
|
Concept
|
Mice, Knockout
|
Concept
|
Mice, Inbred BALB C
|
Concept
|
Mice, Inbred C3H
|
Concept
|
Mice, Nude
|
Concept
|
Mice, SCID
|
Concept
|
Mice, Inbred Strains
|
Concept
|
Mice
|
Concept
|
Mice, Inbred DBA
|
Concept
|
Mice, Mutant Strains
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Mice, Transgenic
|
Academic Article
|
Genetic mapping of a putative tumor suppressor locus that influences tumorigenesis and metastasis in mice.
|
Academic Article
|
Pla2g16 phospholipase mediates gain-of-function activities of mutant p53.
|
Academic Article
|
SV40 T antigen abrogates p53-mediated transcriptional activity.
|
Academic Article
|
Bcl-2 inhibits p53 nuclear import following DNA damage.
|
Academic Article
|
The loss of mdm2 induces p53-mediated apoptosis.
|
Academic Article
|
Loss of p19ARF enhances the defects of Mdm2 overexpression in the mammary gland.
|
Academic Article
|
Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets.
|
Academic Article
|
Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4.
|
Academic Article
|
Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.
|
Academic Article
|
Crippling p53 activities via knock-in mutations in mouse models.
|
Academic Article
|
The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation.
|
Academic Article
|
p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner.
|
Academic Article
|
Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability.
|
Academic Article
|
Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation.
|
Academic Article
|
Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner.
|
Academic Article
|
Transcriptional mechanisms controlling types I and III collagen genes.
|
Academic Article
|
Serotonin 5-HT1C receptors are expressed at high density on choroid plexus tumors from transgenic mice.
|
Academic Article
|
The tumor suppressor p53 regulates its own transcription.
|
Academic Article
|
PML, a growth suppressor disrupted in acute promyelocytic leukemia.
|
Academic Article
|
The organization and expression of the mdm2 gene.
|
Academic Article
|
mdm2 deletion does not alter growth characteristics of p53-deficient embryo fibroblasts.
|
Academic Article
|
Spatial and temporal patterns of expression of epidermal growth factor, transforming growth factor alpha and transforming growth factor beta 1-3 and their receptors in mouse jejunum after radiation treatment.
|
Academic Article
|
Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.
|
Academic Article
|
Overproduction of MDM2 in vivo disrupts S phase independent of E2F1.
|
Academic Article
|
Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.
|
Academic Article
|
Organization, expression, and localization of the murine mdmx gene and pseudogene.
|
Academic Article
|
An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2.
|
Academic Article
|
Disrupting TP53 in mouse models of human cancers.
|
Academic Article
|
Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice.
|
Academic Article
|
A novel genetic modifier of p53, mop1, results in embryonic lethality.
|
Academic Article
|
p53 mutation heterogeneity in cancer.
|
Academic Article
|
p21 delays tumor onset by preservation of chromosomal stability.
|
Academic Article
|
A genetic mouse model for metastatic lung cancer with gender differences in survival.
|
Academic Article
|
Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development.
|
Academic Article
|
The intestinal epithelium compensates for p53-mediated cell death and guarantees organismal survival.
|
Academic Article
|
EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model.
|
Academic Article
|
Mdm4 loss in the intestinal epithelium leads to compartmentalized cell death but no tissue abnormalities.
|
Academic Article
|
Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice.
|
Academic Article
|
E2F3 is a mediator of DNA damage-induced apoptosis.
|
Academic Article
|
You can win by losing: p53 mutations in rhabdomyosarcomas.
|
Academic Article
|
Coexpression of normally incompatible developmental pathways in retinoblastoma genesis.
|
Academic Article
|
Multiple stress signals activate mutant p53 in vivo.
|
Academic Article
|
The mutant p53 mouse as a pre-clinical model.
|
Academic Article
|
DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-?-driven epithelial-mesenchymal transition.
|
Academic Article
|
The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity.
|
Academic Article
|
USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses.
|
Academic Article
|
Tissue-specific expression of p53 in transgenic mice is regulated by intron sequences.
|
Academic Article
|
Analysis of p53 mutants for transcriptional activity.
|
Academic Article
|
Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene.
|
Academic Article
|
The expression of viral and cellular genes in papillomas of the choroid plexus induced in transgenic mice.
|
Academic Article
|
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.
|
Academic Article
|
Deletion of p21 cannot substitute for p53 loss in rescue of mdm2 null lethality.
|
Academic Article
|
Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes.
|
Academic Article
|
Mouse models dissect the role of p53 in cancer and development.
|
Academic Article
|
The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53.
|
Academic Article
|
Germ cell expression of an isolated human endogenous retroviral long terminal repeat of the HERV-K/HTDV family in transgenic mice.
|
Academic Article
|
p53-independent functions of the p19(ARF) tumor suppressor.
|
Academic Article
|
Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.
|
Academic Article
|
Conditional allele of mdm2 which encodes a p53 inhibitor.
|
Academic Article
|
p53 and Fas ligand are required for psoralen and UVA-induced apoptosis in mouse epidermal cells.
|
Academic Article
|
The Brn-3a POU family transcription factor stimulates p53 gene expression in human and mouse tumour cells.
|
Academic Article
|
Mutation at p53 serine 389 does not rescue the embryonic lethality in mdm2 or mdm4 null mice.
|
Academic Article
|
Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389.
|
Academic Article
|
Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53.
|
Academic Article
|
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.
|
Academic Article
|
Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.
|
Academic Article
|
Distinct roles of Mdm2 and Mdm4 in red cell production.
|
Academic Article
|
The oncogenic roles of p53 mutants in mouse models.
|
Academic Article
|
Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos.
|
Academic Article
|
New mouse models of cancer: single-cell knockouts.
|
Academic Article
|
Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence.
|
Academic Article
|
Loss of Mdm4 results in p53-dependent dilated cardiomyopathy.
|
Academic Article
|
Mtbp haploinsufficiency in mice increases tumor metastasis.
|
Academic Article
|
The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.
|
Academic Article
|
Mdm2 and Mdm4 loss regulates distinct p53 activities.
|
Academic Article
|
p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner.
|
Academic Article
|
A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.
|
Academic Article
|
Mouse models of p53 functions.
|
Academic Article
|
Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4.
|
Academic Article
|
A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development.
|
Academic Article
|
Regulation of tissue- and stimulus-specific cell fate decisions by p53 in vivo.
|
Academic Article
|
Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-? (TGF-?).
|
Academic Article
|
Mutant p53 protein, master regulator of human malignancies: a report on the Fifth Mutant p53 Workshop.
|
Academic Article
|
The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.
|
Academic Article
|
Grail as a molecular determinant for the functions of the tumor suppressor p53 in tumorigenesis.
|
Academic Article
|
Mutant p53 prolongs NF-?B activation and promotes chronic inflammation and inflammation-associated colorectal cancer.
|
Academic Article
|
An intron binding protein is required for transformation ability of p53.
|
Academic Article
|
Cyclin E restores p53 activity in contact-inhibited cells.
|
Academic Article
|
The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo.
|
Academic Article
|
Loss of one but not two mdm2 null alleles alters the tumour spectrum in p53 null mice.
|
Academic Article
|
High metastatic potential in mice inheriting a targeted p53 missense mutation.
|
Academic Article
|
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.
|
Academic Article
|
RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.
|
Academic Article
|
The p53-Mdm2 network in progenitor cell expansion during mouse postnatal development.
|
Academic Article
|
Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation.
|
Academic Article
|
The ups and downs of p53 regulation in hematopoietic stem cells.
|
Academic Article
|
ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63.
|
Academic Article
|
The Mdm network and its regulation of p53 activities: a rheostat of cancer risk.
|
Academic Article
|
Tissue-specific expression of the mouse alpha 2(I) collagen promoter. Studies in transgenic mice and in tissue culture cells.
|
Academic Article
|
Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice.
|
Academic Article
|
Mutation of phosphoserine 389 affects p53 function in vivo.
|
Academic Article
|
14-3-3 sigma positively regulates p53 and suppresses tumor growth.
|
Academic Article
|
What have animal models taught us about the p53 pathway?
|
Academic Article
|
Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.
|
Academic Article
|
p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.
|
Academic Article
|
Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair.
|
Academic Article
|
Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers.
|
Academic Article
|
Tissue-specific and age-dependent effects of global Mdm2 loss.
|
Academic Article
|
Therapeutic efficacy of p53 restoration in Mdm2-overexpressing tumors.
|
Academic Article
|
Dissecting the p53-Mdm2 feedback loop in vivo: uncoupling the role in p53 stability and activity.
|
Academic Article
|
Loss of the novel tumour suppressor and polarity gene Trim62 (Dear1) synergizes with oncogenic Ras in invasive lung cancer.
|
Academic Article
|
TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice.
|
Academic Article
|
Mdm2 overexpression and p73 loss exacerbate genomic instability and dampen apoptosis, resulting in B-cell lymphoma.
|
Academic Article
|
Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice.
|
Academic Article
|
p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis.
|
Academic Article
|
MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53.
|
Academic Article
|
Distinct downstream targets manifest p53-dependent pathologies in mice
|
Academic Article
|
Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice
|
Academic Article
|
Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice
|
Academic Article
|
Manipulating the p53 gene in the mouse
|
Academic Article
|
Developing genetically engineered mouse models to study tumor suppression.
|
Academic Article
|
Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity.
|
Academic Article
|
Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice.
|
Academic Article
|
Distinct downstream targets manifest p53-dependent pathologies in mice.
|
Academic Article
|
Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo.
|
Academic Article
|
Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End.
|
Academic Article
|
The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis.
|
Academic Article
|
Tumorigenesis promotes Mdm4-S overexpression.
|
Academic Article
|
Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes.
|
Academic Article
|
Integrative genome analysis of somatic p53 mutant osteosarcomas identifies Ets2-dependent regulation of small nucleolar RNAs by mutant p53 protein.
|
Academic Article
|
Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells.
|
Academic Article
|
Synergistic and additive effect of retinoic acid in circumventing resistance to p53 restoration.
|
Academic Article
|
A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA-/- and mutant-p53.
|
Academic Article
|
Daxx Functions Are p53-Independent In Vivo.
|
Academic Article
|
Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases.
|
Academic Article
|
Constitutive Dicer1 phosphorylation accelerates metabolism and aging in vivo.
|
Academic Article
|
One step at a time.
|
Academic Article
|
CRISPR/Cas9 can mediate high-efficiency off-target mutations in mice in vivo.
|
Academic Article
|
Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination.
|
Concept
|
Mice, 129 Strain
|
Academic Article
|
Transient enhancement of p53 activity protects from radiation-induced gastrointestinal toxicity.
|
Academic Article
|
Men1 maintains exocrine pancreas homeostasis in response to inflammation and oncogenic stress.
|
Academic Article
|
Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo.
|
Academic Article
|
p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo.
|
Academic Article
|
The Common Germline TP53-R337H Mutation Is Hypomorphic and Confers Incomplete Penetrance and Late Tumor Onset in a Mouse Model.
|
Academic Article
|
MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism.
|
Academic Article
|
Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis.
|
Academic Article
|
Wnt/?-catenin-mediated p53 suppression is indispensable for osteogenesis of mesenchymal progenitor cells.
|
Academic Article
|
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer.
|
Academic Article
|
Alterations of the Mdm2 C-Terminus Differentially Impact Its Function In Vivo.
|
Academic Article
|
Differential Gain-of-Function Activity of Three p53 Hotspot Mutants In Vivo.
|
Academic Article
|
EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma.
|
Academic Article
|
Is loss of p53 a driver of ductal carcinoma in situ progression?
|
Academic Article
|
p53 Activation Paradoxically Causes Liver Cancer.
|
Academic Article
|
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss.
|
Academic Article
|
Context matters - Daxx and Atrx are not robust tumor suppressors in the murine endocrine pancreas.
|
Academic Article
|
Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling.
|
Academic Article
|
Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic Program.
|
Academic Article
|
Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants.
|
Academic Article
|
Triple-negative breast tumors are dependent on mutant p53 for growth and survival.
|
Academic Article
|
The histone chaperone function of Daxx is dispensable for embryonic development.
|
Academic Article
|
p53R245W Mutation Fuels Cancer Initiation and Metastases in NASH-driven Liver Tumorigenesis.
|
Academic Article
|
Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo.
|